Skip to main content
. 2014 Oct 13;5:218. doi: 10.3389/fphar.2014.00218

Figure 9.

Figure 9

Comparison of simulated average inhibition of glucose reabsorption mediated by SGLT2 and clinically measured glucose reabsorption inhibition levels during treatment with dapagliflozin. Comparison of the average inhibition of glucose reabsorption mediated by SGLT2 (simulated in the model) and levels of glucose reabsorption inhibition (measured in experiment) on the 14th day following multiple administrations of different doses of dapagliflozin (Komoroski et al., 2009a). Model simulations are presented with 95% confidence bands.